Dogs with dementia show similar brain patterns to humans
Researchers find similarities in brain tissue of dogs and humans with dementia, potentially advancing therapies for humans. A new gene therapy is being explored to treat canine cognitive decline.
USF Health researchers are working on a gene therapy to treat canine cognitive decline, a condition similar to Alzheimer's disease in humans. Aurelie Joly, a research associate, is leading the project to advance the therapy.
The therapy uses a modified virus to deliver genetic instructions into brain cells, allowing them to produce a protective protein that helps shield brain cells from damage. Joly says studying cognitive decline in dogs could help advance therapies for humans.
Dogs develop cognitive decline naturally as they age, making them a valuable model for studying the disease. Existing treatments for dogs primarily address symptoms, but the new therapy aims to target the underlying disease.
A recent study found that dogs with canine cognitive dysfunction (CCD) have similar brain patterns to humans with Alzheimer's disease. The study examined brain tissue from 24 senior dogs and found Aβ deposition consistent with early-stage Alzheimer's-like pathology.
Dr. Julie Moreno, a neurotoxicologist, says the findings emphasize the vital role dogs can play in helping us better understand cognitive diseases such as Alzheimer's. The study's results could help inform medical care for people with dementia.
The research was conducted by a team of scientists, including Dr. Caitlin Latimer, who examined brain tissue from dogs with CCD. They found that the dogs' brain tissue showed similar patterns to those found in humans with Alzheimer's disease.
The study's findings have implications for the development of new treatments for Alzheimer's disease. By studying cognitive decline in dogs, researchers may be able to gain a better understanding of the disease and develop more effective therapies.
Key facts
- Dogs with canine cognitive dysfunction (CCD) show similar brain patterns to humans with Alzheimer's disease
- A new gene therapy is being explored to treat canine cognitive decline
- The therapy uses a modified virus to deliver genetic instructions into brain cells
- Dogs develop cognitive decline naturally as they age, making them a valuable model for studying the disease
Three perspectives
Neutral
The research highlights the potential for dogs to play a role in advancing our understanding of cognitive diseases such as Alzheimer's. The study's findings have implications for the development of new treatments, but more research is needed to fully understand the disease.
Positive
The discovery of similar brain patterns in dogs and humans with dementia is a promising development in the search for new treatments. The use of gene therapy to treat canine cognitive decline could lead to breakthroughs in the treatment of Alzheimer's disease.
Negative
The study's findings also highlight the limitations of current treatments for canine cognitive decline, which primarily address symptoms rather than the underlying disease. More research is needed to develop effective therapies for both dogs and humans.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.